Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
OrthoMend is a comprehensive dietary supplement formulated to support joint health and connective tissue integrity. Developed by Ortho Molecular Products, it combines several key ingredients known for their roles in cartilage synthesis and inflammation modulation. The formulation includes glucosamine sulfate and chondroitin sulfate, which serve as essential building blocks for the glycosaminoglycan matrix in articular cartilage. Methylsulfonylmethane (MSM) is included as a source of organic sulfur to support collagen cross-linking and reduce oxidative stress. Additionally, the supplement contains Vitamin C and manganese, which act as cofactors for enzymes involved in the biosynthesis of collagen and proteoglycans. OrthoMend is primarily indicated for individuals seeking to maintain joint mobility, reduce discomfort associated with osteoarthritis, and support the structural repair of connective tissues.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on OrthoMend.